Lizzy Lawrence leads STAT’s coverage of the Food and Drug Administration. She was previously a medical devices reporter. You can reach Lizzy on Signal at lizzylaw.53. WASHINGTON — Health secretary ...
NEW YORK, NY / ACCESS Newswire / November 5, 2025 / Plastic isn’t just everywhere – it’s everything. From the food we buy to the cars we drive, the global plastics economy is worth more than $800 ...
A stroll down the supplement aisle is a walk filled with hope. One pill offers stronger hair and nails. Another promises better memory (which will help when you have to remember to take all these ...
The agency says it will continue testing more products and update its list as new items are identified as potential health risks. Stacey Leasca is an award-winning journalist with nearly two decades ...
Bypassing its standard pathways for scientific discussions, FDA has recently held a slew of so-called "expert panels" that sidestep legal procedures and ethics guardrails, raising concern about cherry ...
As 2025 draws to a close, the state of the federal system of regulatory affairs in the United States continues to operate in a somewhat chaotic fashion. FDA has perhaps been most affected by changes ...
The FDA, concerned about potential harm to patients, sought increased oversight of these products by classifying them as medical devices. This change was prudent, the FDA argued, due to the growing ...
The landscape of FDA medical device regulation has undergone a significant transformation. Today's regulatory environment presents both familiar challenges and entirely new complexities that device ...
Almost every Senate Republican on Thursday urged the Food and Drug Administration (FDA) to “reevaluate” whether a newly approved generic version of the abortion drug mifepristone should stay on the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback